selected publications
- Paving the Way for Cancer Therapy a Nano Step at a Time. The Journal of pharmacology and experimental therapeutics. 2023 Academic Article GET IT
-
GLS2 Is a Tumor Suppressor and a Regulator of Ferroptosis in Hepatocellular Carcinoma.
Cancer research.
2022
Academic Article
GET IT
Times cited: 106 - Increased p53 expression induced by APR-246 reprograms tumor-associated macrophages to augment immune checkpoint blockade. The Journal of clinical investigation. 2022 Academic Article GET IT
- Calreticulin mutant myeloproliferative neoplasms induce MHC-I skewing, which can be overcome by an optimized peptide cancer vaccine. Science translational medicine. 2022 Academic Article GET IT
-
p53 Frameshift Mutations Couple Loss-of-Function with Unique Neomorphic Activities.
Molecular cancer research : MCR.
2021
Academic Article
GET IT
Times cited: 8 -
The roles and regulation of MDM2 and MDMX: it is not just about p53.
Genes & development.
2021
Review
GET IT
Times cited: 101 -
p21 can be a barrier to ferroptosis independent of p53.
Aging.
2020
Academic Article
GET IT
Times cited: 50 -
MDM2 and MDMX promote ferroptosis by PPARĪ±-mediated lipid remodeling.
Genes & development.
2020
Academic Article
GET IT
Times cited: 220